(Q43638512)

25 November 2017

title

Delivery of HFA and CFC salbutamol from spacer devices used in infancy (English)

1 reference

25 November 2017

0 references

1 reference

Dubus JC

1

1 reference

25 November 2017

Rhem R

series ordinal

2

1 reference

25 November 2017

Dolovich M

series ordinal

3

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

International Journal of Pharmaceutics

25 November 2017

published in

1 reference

25 November 2017

volume

222

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

101-108

1 reference

Choosing the metered-dose inhaler spacer or holding chamber that matches the patient's need: evidence that the specific drug being delivered is an important consideration

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Effect of electrostatic charge in plastic spacers on the lung delivery of HFA-salbutamol in children

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Inhalational drug delivery from seven different spacer devices

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devices

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Optimum use of a spacer device

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Standards for bioequivalence of inhaled products

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Bioequivalence of inhaled drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Comparison of non-chlorofluorocarbon-containing salbutamol and conventional inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

In vitro comparison of beclomethasone and salbutamol metered-dose inhaler aerosols inhaled during pediatric tidal breathing from four valved holding chambers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

In vitro comparison of salbutamol hydrofluoroalkane (Airomir) metered dose inhaler aerosols inhaled during pediatric tidal breathing from five valved holding chambers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Relative bioavailability of salbutamol to the lung following inhalation using metered dose inhalation methods and spacer devices.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Metered dose inhaler and nebuliser in acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Lung delivery of salbutamol by dry powder inhaler (Turbuhaler) and small volume antistatic metal spacer (Airomir CFC-free MDI plus NebuChamber)

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Lung delivery of non-CFC salbutamol via small volume metal spacer and large volume plastic spacer devices compared with an open vent jet nebulizer

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Early lung absorption profile of non-CFC salbutamol via small and large volume plastic spacer devices

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Transition to CFC-free metered dose inhalers--into the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Randomised trial spacer v nebuliser for acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Washing plastic spacers in household detergent reduces electrostatic charge and greatly improves delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Electrostatic charge on a plastic spacer device influences the delivery of salbutamol

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Aerosol delivery to wheezy infants: a comparison between a nebulizer and two small volume spacers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

Salbutamol delivery from a hydrofluoroalkane pressurized metered-dose inhaler in pediatric ventilator circuits: an in vitro study

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2801%2900702-5

7 January 2021

10.1016/S0378-5173(01)00702-5

Identifiers

DOI

1 reference

25 November 2017

1 reference